Saturday, 15 November 2008

New Discovery for Tamoxifen Resistance

Tamoxifen has been hailed as revolutionary in the treatment of breast cancer. After five years of treatment some women develop resistance and the cancer can return. Cancer Research UK Scientists in Cambridge have found a reason as to why some women develop this resistance. See the press release here. The full article is available in Nature as ERBB2 regulation by Estrogen Receptor-Pax2 determines tamoxifen response. (2008) Nature. Published Wednesday 12 November.
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

About Us

The Kostoris Library offers a friendly and pleasant environment for studying.
Resources include:
> A large collection of online journals (which can be accessed from the library's web pages)
> A journal archive of specialist literature.
> A comprehensive specialist book collection and specialist cancer resources.
> A comprehensive range of services to help you keep up to date with the latest published research literature and health news.

Find out more on the library website

The views expressed on News@Kostoris Library website/weblog are from library staff and do not necessarily reflect the views of our employer. We uphold due respect to our institution, its employees, customers, partners, and competitors.